Thyrotropin Releasing Hormone (TRH) (Human, Ovine, Porcine, Rat)

CAS: 24305-27-9

Ref. 3D-PTR-4011

Informação sobre produto

• Nome: Thyrotropin Releasing Hormone (TRH) (Human, Ovine, Porcine, Rat)
• Sinónimos: Pyr-His-Pro-NH2 • H2O, Protirelin, Lopremone, Rifathyroin, Thyroliberin, Thypinone, Synthetic TRH, TSH-releasing factor, (Pyro)-<span class="text-smallcaps">L</smallcap>-glutamic acid-<smallcap>L</smallcap>-histidine-<smallcap>L</span>-proline-NH₂, (Pyro)-L-glutamic acid-L-histidine-L-proline-NH2, 252: PN: WO2010033207 SEQID: 378 claimed protein, 5-Oxo-<span class="text-smallcaps">L</smallcap>-prolyl-<smallcap>L</smallcap>-histidyl-<smallcap>L</span>-prolinamide, 83: PN: US20090175821 PAGE: 403 claimed protein, <span class="text-smallcaps">L</smallcap>-Prolinamide, 5-oxo-<smallcap>L</smallcap>-prolyl-<smallcap>L</span>-histidyl-, <span class="text-smallcaps">L</smallcap>-Pyroglutamyl-<smallcap>L</smallcap>-histidyl-<smallcap>L</span>-prolinamide, <span class="text-smallcaps">L</smallcap>-Pyroglutamyl-<smallcap>L</smallcap>-histidyl-<smallcap>L</span>-proline amide, Abbott 38579, Antepan, Fda 1725, L-Pyroglutamyl-L-histidyl-L-prolinamide, L-Pyroglutamyl-L-histidyl-L-proline amide, Prem, Protirelina, Protireline, Relefact TRH, Rifotironin, Ro 8-6270/9, Stimu TSH, Synthetic TRF, Synthetic TSH-releasing factor, Synthetic TSH-releasing hormone, Synthetic thyrotropin-releasing factor, Synthetic thyrotropin-releasing hormone, TRF, TRH, TSH-releasing hormone, Thyrefact, Thyroid releasing hormone, Thyroid-stimulating hormone-releasing factor, Thyrotropic hormone-releasing factor, Thyrotropic hormone-releasing hormone, Thyrotropic releasing hormone, Thyrotropic-releasing factor, Thyrotropin-releasing factor, Thyrotropin-releasing hormone, Tsh-Rf
• CAS: 24305-27-9

Descrição

Thyrotropin Releasing Hormone (TRH) is a hormone that stimulates the release of thyroid hormones. TRH has been used to diagnose and treat conditions such as autoimmune diseases, infectious diseases, and thyroid disease. It is also used in the treatment of patients with hypothyroidism who are not responding to levothyroxine therapy. TRH is administered intravenously or intramuscularly. This drug is primarily used for diagnostic purposes in women who have symptoms of hyperthyroidism but normal serum levels of TSH and thyroxine levels. TRH administration can result in a rise in serum prolactin levels, which may be useful for diagnosis of the condition hyperprolactinemia.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 380.4 g/mol
• Fórmula: C₁₆H₂₂N₆O₄•H₂O
• Pureza: Min. 95%